Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
S100A13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRPS16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC44A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLXIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANXA11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EED - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BMP8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAR1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLCO3A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLCO5A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLCCI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLEC7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACER3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPPED2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CERS6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on